Novel 8-Substituted Dipyridodiazepinone Inhibitors with a Broad-Spectrum of Activity against HIV-1 Strains Resistant to Non-nucleoside Reverse Transcriptase Inhibitors-Reference-Cited by-同舟云学术

Novel 8-Substituted Dipyridodiazepinone Inhibitors with a Broad-Spectrum of Activity against HIV-1 Strains Resistant to Non-nucleoside Reverse Transcriptase Inhibitors

Published:2005-07-29 Issue:17 Volume:48 Page:5580-5588
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

O'Meara Jeff A.¹,Yoakim Christiane¹,Bonneau Pierre R.¹,Bös Michael¹,Cordingley Michael G.¹,Déziel Robert¹,Doyon Louise¹,Duan Jianmin¹,Garneau Michel¹,Guse Ingrid¹,Landry Serge¹,Malenfant Eric¹,Naud Julie¹,Ogilvie William W.¹,Thavonekham Bounkham¹,Simoneau Bruno¹

Affiliation:

1. Boehringer Ingelheim (Canada) Ltd., Research & Development, 2100 Cunard Street, Laval, Québec, Canada H7S 2G5

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm050255t

Reference19 articles.

1. 1998 revision to the British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals

2. Targets and strategies for the antiviral chemotherapy of AIDS

3. Crystal Structure at 3.5 Å Resolution of HIV-1 Reverse Transcriptase Complexed with an Inhibitor

4. Non-Nucleoside HIV-1 Reverse Transcriptase (RT) Inhibitors: Past, Present, and Future Perspectives

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fullerene derivatives as dual inhibitors of HIV-1 reverse transcriptase and protease;Bioorganic & Medicinal Chemistry Letters;2021-01

2. Molecular design opportunities presented by solvent‐exposed regions of target proteins;Medicinal Research Reviews;2019-04-19

3. Challenges and approaches in the discovery of human immunodeficiency virus type‐1 non‐nucleoside reverse transcriptase inhibitors;Medicinal Research Reviews;2018-11-11

4. Preclinical Profile of BI 224436, a Novel HIV-1 Non-Catalytic-Site Integrase Inhibitor;Antimicrobial Agents and Chemotherapy;2014-03-24

5. N- versus O-alkylation: Utilizing NMR methods to establish reliable primary structure determinations for drug discovery;Bioorganic & Medicinal Chemistry Letters;2013-08